ExploreConditionpost-donation skeletal pain
Condition

post-donation skeletal pain

Also known as: post-donation skeletal pain
3 findings 1 paper 3 related entities View in graph →

Related entities

interventions
outcomes
studys

Findings (27)

None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83

Papers (1)